Can Artificial Intelligence Help Personalize Treatment…

Can Artificial Intelligence Help Personalize Treatment Decisions? New Research Introduces an Interpretable AI Framework Every patient responds differently to treatment. While one therapy may work well for one individual, another patient with the same condition may benefit from a completely different approach. This variability has driven growing interest in personalized medicine, where treatment decisions are tailored to an individual's unique clinical characteristics. A new study published in Scientific Reports introduces an artificial intelligence (AI)-based framework designed to improve these decisions. Called Censoring-Adjusted Tree-based Reinforcement Learning (CA-TReL), the model aims to identify personalized treatment strategies from real-world clinical data while addressing one of the biggest challenges in medical research: incomplete patient follow-up, also known as censored data. Many medical conditions require treatment decisions to be made over time rather than all at once. For example, clinicians may need to adjust therapy based on: Disease progression Treatment response Side effects Laboratory results New clinical findings These step-by-step, individualized treatment pathways are known as Dynamic Treatment Regimens (DTRs). Rather than following a single fixed treatment plan, DTRs help clinicians determine what treatment should be given, to whom, and at what stage of care. Learning the best treatment strategies from real-world patient data is not always straightforward. In many long-term studies: Patients move away. Follow-up ends early. Participants withdraw. Outcomes are not fully observed. Researchers refer to these incomplete observations as censored data. Ignoring these missing